Our reports showed that CKD increases vascular inflammation via uremic toxins as danger associated molecular patterns (DAMPs) (16–19)-caspase 1-inflamamsome (20) mediated pathway; and secretomes in peripheral blood mononuclear cells (PBMC) may play significant roles in promoting inflammation in CKD transition to end stage renal disease (21). Here, CASP1 is linked to chronic kidney disease.